Rapid Detection of COVID-19 by Portable and Connected Biosensor

University Hospital, Lille200 enrolled

Overview

The objective of study is to estimate the sensitivity and specificity of the COR-DIAL based on nasopharyngeal samples taken at the patient's admission in relation to the final diagnosis of COVID-19 made by the medical team.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Sars-CoV2

Interventions

COVID-19 RT-PCRDIAGNOSTIC_TEST

Nasopharyngeal swabs for COVID-19 RT-PCR

BiosensorDIAGNOSTIC_TEST

Portable and Connected Biosensor viral

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female or child without age limit * Admitted to a Reference Health Establishment in an emergency unit, hospitalisation or intensive care unit for suspicion of SARS-CoV-2 infection, regardless of the clinical presentation and degree of severity. * Patient to be diagnosed using a PCR test on nasopharyngeal swab. * Social insured Exclusion Criteria: * Atypical or suspicious cases without a final diagnosis of COVID-19 positive or negative * Patient refusal to participate

Locations (1)

CHU lille

Lille, France

Outcomes

Primary Outcomes

Sensitivity and specificity of the COR-DIAL based on nasopharyngeal swabs taken on admission of the patient compared to the final diagnosis of COVID-19 made by the medical team

Time frame: Baseline (at admission)

Secondary Outcomes

Cohen's Kappa Coefficient for concordance for the diagnosis of CoV-2-SARS between PCR and COR-DIAL based on nasopharyngeal swabs taken on patient admission

Time frame: Baseline (at admission)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.